Filtered By:
Cancer: Breast Cancer
Drug: Aspirin
This page shows you your search results in order of date.
Order by Relevance | Date
Total 73 results found since Jan 2013.
Aspirin Affects MDA-MB-231 Vesicle Production and Their Capacity to Induce Fibroblasts towards a Pro-Invasive State
In conclusion, ASA can interfere with tumor communication by reducing EV secretion by breast tumor cells as well as by interfering with their capacity to stimulate fibroblasts to become CAFs.PMID:37569393 | DOI:10.3390/ijms241512020
Source: Cancer Control - August 12, 2023 Category: Cancer & Oncology Authors: Rafaela de Assiz Louback Karina Martins-Cardoso Luzineide W Tinoco Federica Collino Ana Paula D N de Barros Anneliese Fortuna-Costa Robson Q Monteiro Maria Isabel Doria Rossi Rafael Soares Lindoso Source Type: research
DDIT4 Downregulation by siRNA Approach Increases the Activity of Proteins Regulating Fatty Acid Metabolism upon Aspirin Treatment in Human Breast Cancer Cells
Curr Issues Mol Biol. 2023 May 28;45(6):4665-4674. doi: 10.3390/cimb45060296.ABSTRACTRepositioning of aspirin for a more effective breast cancer (BC) treatment requires identification of predictive biomarkers. However, the molecular mechanism underlying the anticancer activity of aspirin remains fully undefined. Cancer cells enhance de novo fatty acid (FA) synthesis and FA oxidation to maintain a malignant phenotype, and the mechanistic target of rapamycin (mTORC1) is required for lipogenesis. We, therefore, aimed to test if the expression of mTORC1 suppressor DNA damage-inducible transcript (DDIT4) affects the activity of...
Source: Current Issues in Molecular Biology - June 27, 2023 Category: Molecular Biology Authors: Aist ė Savukaitytė Agn ė Bartnykaitė Justina Bekampyt ė Rasa Ugenskien ė Elona Juozaityt ė Source Type: research
